Vanguard Fiduciary Trust
MGNX icon

Vanguard Fiduciary Trust’s MacroGenics MGNX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Buy
420,106
+80,017
+24% +$303K ﹤0.01% 2688
2026
Q1 		$983K Buy
+340,089
New +$725K ﹤0.01% 2919

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Fiduciary Trust's MGNX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its MacroGenics (MGNX) stake by 24% in Q2 2026, buying an estimated $303K and bringing the position to 420,106 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2688.

Vanguard Fiduciary Trust first reported a position in MGNX in Q1 2026 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Vanguard Fiduciary Trust held 420,106 shares of MacroGenics worth $1.94M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 80,017 MacroGenics shares in Q2 2026, an estimated $303K.
  • MacroGenics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2688 holding.
  • Vanguard Fiduciary Trust first reported a position in MacroGenics in Q1 2026 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.